The present invention relates to apparatus for aspirating, irrigating and/or cleansing wounds, and a method of treating wounds and the exudates from such wounds using such apparatus for aspirating, irrigating and/or cleansing wounds.
The invention relates in particular to such an apparatus and method that can be easily applied to a wide variety of wounds, to cleanse them of materials that are deleterious to wound healing, whilst retaining materials that are beneficial in some therapeutic aspect, in particular to wound healing.
Before the present invention, aspirating and/or irrigating apparatus therefor were known, and tended to be used to remove wound exudate during wound therapy. In known forms of such wound therapy, the offtake from the wound, especially when in a highly exuding state, is voided to waste, e.g. to a collection bag or vessel which is removed when full and discarded as clinical waste. Materials deleterious to wound healing are removed in this way.
The volume of such exudates in some cases is very high and the collection bag or vessel can become relatively rapidly filled. If a collection bag or vessel of greater volume is used to extend the period between which the vessel needs to be emptied or changed this can have disadvantageous consequences on the portability of such apparatus and its convenience of use making the device or apparatus cumbersome and heavy. Furthermore, changing the collection bag or vessel is costly, time consuming and results in cessation of therapy.
In our co-pending International patent application, WO 2004/037334, apparatus, a wound dressing and a method for aspirating, irrigating and cleansing wounds are described. In very general terms, this invention describes the treatment of a wound by the application of topical negative pressure (TNP) therapy for aspirating the wound together with the further provision of additional fluid for irrigating and/or cleansing the wound, which fluid, comprising both wound exudates and irrigation fluid, is then drawn off by the aspiration means and circulated through means for separating the beneficial materials therein from deleterious materials. The materials which are beneficial to wound healing are recirculated through the wound dressing and those materials deleterious to wound healing are discarded to a waste collection bag or vessel.
In our co-pending International patent application, WO 2005/04670, apparatus, a wound dressing and a method for cleansing a wound using aspiration, irrigation and cleansing wounds are described. Again, in very general terms, the invention described in this document utilises similar apparatus to that in WO 2004/037334 with regard to the aspiration, irrigation and cleansing of the wound, however, it further includes the important additional step of providing heating means to control the temperature of that beneficial material being returned to the wound site/dressing so that it is at an optimum temperature, for example, to have the most efficacious therapeutic effect on the wound.
Our co-pending International patent application, WO 2005/105180, apparatus and a method for the aspiration, irrigation and/or cleansing of wounds are described. Again, in very general terms, this document describes similar apparatus to the two previously mentioned documents hereinabove but with the additional step of providing means for the supply and application of physiologically active agents to the wound site/dressing to promote wound healing.
There are available various forms of apparatus for topical negative pressure (TNP) therapy of wounds, the apparatus being intended to be portable and for use by a patient outside of hospitalisation, for example, in the home, outdoors or even at work so that the therapy can be continuously applied to a wound which does not necessarily require hospitalisation. In such apparatus, a vessel or canister is provided for receiving wound exudates, the canister being gradually filled by aspiration means such as a pump which applies a negative (below atmospheric) pressure. Eventually the canister becomes full and must be removed and discarded and a fresh, empty canister installed. Clearly, the less frequently this canister change is required the better.
In all of the above examples it is clearly beneficial to be able to reduce the volume of exudate which is collected in an apparatus waste container and consequently reduce the weight thereof and also to decrease the frequency at which the waste container need be changed and discarded. This may perhaps be especially so where there is additional fluid being provided to the wound site/dressing for various reasons and which fluid inevitably adds to the volume of waste which is collected and eventually discarded.
It is an object of the present invention to provide apparatus and a method for reducing the rate of collection of waste which eventually needs to be discarded. Consequently, a further objective is to reduce the frequency at which waste containers need to be changed in a given apparatus.
According to a first aspect of the present invention there is provided apparatus for use in wound therapy of mammals, the apparatus comprising:
A dressing covering the wound, the dressing being substantially sealed to prevent ingress of ambient atmospheric air to the wound;
Aspiration means operably connected to a space between the dressing and the wound by an aspiration conduit sealed to the point of entry between wound and dressing against ingress of ambient atmosphere, said conduit being for aspiration of said wound and for removal of fluid from said space between said wound and said dressing;
A waste container for receiving aspirated fluid to be discarded operably connected to said aspiration conduit; and
Heating means for heating said fluid in order to increase the vapour pressure thereof and to cause evaporation to reduce the volume of the fluid in the waste container.
In the present invention the dressing is effectively sealed to the skin surrounding the wound. However, the term “sealed” is not an absolute requirement or practically attainable since many flexible dressing membrane materials forming the wound cover are composed of semi-permeable plastics materials which are well known to those skilled in the art. Furthermore, there is almost inevitably some leakage between the skin to which the sealing dressing material is adhered, usually by well known pressure sensitive adhesives, due to hairs and/or other skin surface irregularities and/or imperfections which are not easily completely sealed in absolute terms. The types of self adhesive, flexible dressing drape materials which are ordinarily used in TNP type therapy for sealing membranes over and around wounds are well know to those skilled in the art and will not be elaborated on further herein unless necessary.
In one embodiment of the apparatus according to the present invention, the aspiration means comprises a pump which applies a negative pressure to the wound site in the space between the wound and the sealed dressing. For the avoidance of doubt, the term “negative pressure” used herein means a pressure lower than ambient atmospheric pressure. Such negative pressure is generally at a lowest pressure of 250 mmHg below atmospheric pressure but more usually within a range of 50-200 mmHg below atmospheric pressure.
There are many types of pump which may be used to apply a negative pressure and include peristaltic, vane, diaphragm and the like, for example.
In a TNP apparatus where only a suction force is applied to the wound, the waste material container may be interposed between the aspiration means and the conduit in operable connection to the wound site thus, the aspiration means or pump is applying its negative pressure through the waste container. However, in alternative embodiments the aspiration means may be interposed between the wound site/dressing and the waste container.
The heating means may be any which is suitable for the apparatus in question and may comprise a heating mat or blanket type of material in direct contact with the waste container, for example, or may be associated with the aspiration conduit to heat the waste fluid before it reaches the waste container. Other forms of heating such as cartridge heaters and infrared may be employed. Infrared has the advantage that it is non-contact and the majority of the energy may be coupled into the fluid as suitable non-absorbing canister materials may be chosen.
In alternative embodiments, the heating means may be formed integrally with the waste container or canister and may also include integral thermocouples or thermistors to allow the temperature to be controlled by feedback loop from the control system.
In accordance with the first aspect of the invention an apparatus which is intended for TNP therapy only may be provided in a waste fluid container therefor with one or more filters elements, for example, a hydrophobic filter, which prevents passage or egress of liquid and bacteria but permits egress of vapour, for example, water vapour, in a gaseous state.
Such filter elements, for example, a 0.2 micron pore size filter and/or a 1 micron pore size, may advantageously be incorporated into an exit duct of the waste canister or container. This had the advantage that it provides certainty that the filter has been changed regularly, i.e. when the container has been discarded when full and furthermore, seals the exit duct/container when removed from the apparatus.
In a preferred embodiment of the apparatus of the present invention there is further provided a supply of gas such as air, for example, to the fluid in the waste container which gas supply is in effect a sparge gas supply which may be arranged to pass through the fluid waste to influence constituents such as water, for example, having a lower vapour pressure to be removed preferential by the gas supply. However, the sparge gas may merely discharge into the waste container with the aspirated waste fluid without actually flowing through the waste fluid already collected in the waste container depending upon the arrangement and type of heating means employed.
The waste container also preferably has a connection to pump means to remove the fluid vapour so produced. The pump means may be the same as the aspiration means or may be additional thereto so as to provide a separate flow of gas bubbles through the waste fluid in the waste container. Alternatively or in addition thereto, the gas supply may be a gas bleed provided by suitable valve means to admit a bleed of gas into the aspiration conduit leading from the wound site dressing.
In a further preferred modified embodiment of the present invention the apparatus may further comprise a supply of a gas to the wound site/dressing. Such a gas supply to wound site dressing may be provided by a separate conduit leading into the dressing and may be either a separately provided gas supply or may be a gas bleed into the dressing provided as a bleed gas via suitable valve means and drawn through the dressing by the aspiration means.
The gas may be air or any other suitable gas which is compatible with the wound. This gas supply may, in effect, be the gas supply referred to above as a sparge gas but where the flow of gas is first directed through the wound site/dressing by means of a separate, second bleed gas conduit which is sealed into the wound site/dressing in a similar manner as the aspirant conduit, before being drawn off by the aspiration means to the waste container. The aspirant conduit again allowing the bleed gas supply to be drawn through the waste fluid by the aspiration means. The provision of the bleed gas to the wound site/dressing increase the concentration of volatiles by increasing the surface area and number of nucleation sites for evaporation due to the bubbles and also increases the mass transfer of fluid through the system due to the greater mass of gas passing through the system which in turn is more saturated therefore promoting a greater mass leaving the system.
The provision of a bleed gas may have physiological effects or may serve to reduce the bioburden and/or odour throughout the fluid system of the wound and apparatus by diluting or reacting with or simply flushing through the system more quickly gases such as ozone, nitrous oxide and other gases which may be generated. A gas bleed to the wound site/dressing is particularly beneficial where the wound site/dressing is provided with additional fluid for cleansing and/or irrigation of the wound. The ability to aerate larger quantities of exudates and other fluid prior to reaching the waste container accelerates the evaporation process and removal of liquid which would otherwise accumulate in the waste bottle. It should be understood that the additional fluid supplied to the wound for cleansing and/or irrigation may contain physiologically active agents, may be heated to body temperature, for example, and the exudates from the wound site may be prior treated to remove beneficial agents in the exudates which may be recirculated to the wound, as disclosed in the three co-pending International patent applications of common ownership herewith and mentioned hereinabove, and that only the fluid ultimately destined for the waste container is treated according to the present invention.
In an alternative preferred embodiment the waste fluid may be discharged into the waste container in the form of atomised droplets so as to increase the evaporation rate of the fluid and some of which vapour may be drawn off to a separate receptacle, for example, and discarded.
In a further alternative preferred embodiment the waste fluid may be discharged over the area of a heated plate member in the waste container, for example, the heated plate member being inclined so that the fluid flows relatively slowly to a lower part of the plate member thus having a relatively extended period in which to be heated and being in the form of a relatively thin film. Thus, the rate of evaporation may be increased.
According to a second aspect of the present invention there is provided a method of treating wound exudates with the apparatus according to the first aspect of the present invention.
In order that the present invention may be more fully understood examples, by way of illustration only, will be described with reference to the following drawings, of which:
Referring now to the drawings and where
The effect of the vacuum pump 30 aspirating the wound 12 by the tube 14 is to create a vacuum therein so as to draw a supply of bleed air into the wound via the tube 16. The amount of or rate of bleed air is controlled by outputs 74 from the control unit 72 to the vacuum regulator 46 in response to the inputs 76 from the various sensors in the apparatus. Thus, the bleed air is drawn into the wound site by the vacuum applied by the pump 30 and is also withdrawn by the aspiration tube 14 by the vacuum pump together with the wound exudates and the irrigant fluid 68. The waste fluid 80 being withdrawn from the wound site 12 is aerated by the bleed air supply and is delivered to the waste bottle 32 by the tube 14. The waste fluid in the bottle 32 is heated by the heater 70 to a predetermined temperature set in the control system and with the flow of bleed air through the waste fluid 80 vapour is drawn off through the line 34 and discharged via the filter 40.
A system was set up as in the above schematic and the pressure was set up 100 mmHg below atmospheric at the wound site 12. The air bleed was adjusted to 0.2 l/min and the heater 70 set to 65.degree. C. and allowed to stabilise. Saline was used as the irrigant fluid 68 and delivered to the wound 12 at a fixed rate to represent fluid coming from the wound 12. The mass of fluid delivered was recorded together with the mass of fluid collected in the waste bottle 32. For the waste bottle a glass bottle was used with Hawco (trade mark) 20 watt silicon heater mat glued to the base of the bottle. The conditions were by no means optimised but, however, the results indicated that over a 24 hour period a mass of 45 g of fluid was evaporated. Thus, with suitable optimisation of the system it is expected that far higher levels of evaporation may be easily achieved.
This heating tube may be used in the apparatus of
Number | Date | Country | Kind |
---|---|---|---|
0712763.2 | Jul 2007 | GB | national |
This application is a continuation application of U.S. application Ser. No. 12/667,232, filed Dec. 29, 2009, which is a U.S. National Phase of the International Application No. PCT/GB2008/050510 filed Jun. 27, 2008 designating the U.S. and published on Jan. 8, 2009 as WO 2009/004370, which claims priority of Great Britain Patent Application No. 0712763.2 filed Jul. 2, 2007. The disclosures of these prior applications are incorporated by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
2280915 | Johnson | Apr 1942 | A |
3874387 | Barbieri | Apr 1975 | A |
3993080 | Loseff | Nov 1976 | A |
4112947 | Nehring | Sep 1978 | A |
4136696 | Nehring | Jan 1979 | A |
4184510 | Murry et al. | Jan 1980 | A |
4224945 | Cohen | Sep 1980 | A |
4316466 | Babb | Feb 1982 | A |
4382441 | Svedman | May 1983 | A |
4465485 | Kashmer et al. | Aug 1984 | A |
4540412 | Van Overloop | Sep 1985 | A |
4573965 | Russo | Mar 1986 | A |
4710165 | McNeil et al. | Dec 1987 | A |
4740202 | Stacey | Apr 1988 | A |
4778446 | Jensen | Oct 1988 | A |
4792328 | Beck et al. | Dec 1988 | A |
4795448 | Stacey et al. | Jan 1989 | A |
4921488 | Maitz et al. | May 1990 | A |
4936834 | Beck et al. | Jun 1990 | A |
4969880 | Zamierowski | Nov 1990 | A |
4979944 | Luzsicza | Dec 1990 | A |
5002539 | Coble | Mar 1991 | A |
5009635 | Scarberry | Apr 1991 | A |
5055198 | Shettigar | Oct 1991 | A |
5073172 | Fell | Dec 1991 | A |
5100396 | Zamierowski | Mar 1992 | A |
5176663 | Svedman et al. | Jan 1993 | A |
5261893 | Zamierowski | Nov 1993 | A |
5328614 | Matsumura | Jul 1994 | A |
5358494 | Svedman | Oct 1994 | A |
5380280 | Peterson | Jan 1995 | A |
5429601 | Conley et al. | Jul 1995 | A |
5449347 | Preen et al. | Sep 1995 | A |
5466229 | Elson | Nov 1995 | A |
5498338 | Kruger et al. | Mar 1996 | A |
5549584 | Gross | Aug 1996 | A |
5549585 | Maher et al. | Aug 1996 | A |
5636643 | Argenta et al. | Jun 1997 | A |
5637093 | Hyman et al. | Jun 1997 | A |
5645081 | Argenta et al. | Jul 1997 | A |
5759570 | Arnold | Jun 1998 | A |
5954680 | Augustine | Sep 1999 | A |
5997733 | Wilbur et al. | Dec 1999 | A |
6110197 | Augustine et al. | Aug 2000 | A |
6135116 | Vogel et al. | Oct 2000 | A |
6159160 | Hsei et al. | Dec 2000 | A |
6229286 | Tokuyama | May 2001 | B1 |
6368311 | Valerio | Apr 2002 | B1 |
6398767 | Fleischmann | Jun 2002 | B1 |
6458109 | Henley et al. | Oct 2002 | B1 |
6465708 | Augustine | Oct 2002 | B1 |
6520982 | Boynton et al. | Feb 2003 | B1 |
6626827 | Felix et al. | Sep 2003 | B1 |
6648862 | Watson | Nov 2003 | B2 |
6676610 | Morton et al. | Jan 2004 | B2 |
6685681 | Lockwood et al. | Feb 2004 | B2 |
6695823 | Lina et al. | Feb 2004 | B1 |
6695824 | Howard et al. | Feb 2004 | B2 |
6752794 | Lockwood et al. | Jun 2004 | B2 |
6755807 | Risk, Jr. et al. | Jun 2004 | B2 |
6764462 | Risk, Jr. et al. | Jul 2004 | B2 |
6800074 | Henley et al. | Oct 2004 | B2 |
6824533 | Risk, Jr. et al. | Nov 2004 | B2 |
6951553 | Bubb et al. | Oct 2005 | B2 |
7022113 | Lockwood et al. | Apr 2006 | B2 |
7042180 | Terry et al. | May 2006 | B2 |
7066949 | Gammons et al. | Jun 2006 | B2 |
7077832 | Fleischmann | Jul 2006 | B2 |
7092797 | Gaines et al. | Aug 2006 | B2 |
7108683 | Zamierowski | Sep 2006 | B2 |
7128735 | Weston | Oct 2006 | B2 |
7144390 | Hannigan et al. | Dec 2006 | B1 |
7160273 | Greter et al. | Jan 2007 | B2 |
7195624 | Lockwood | Mar 2007 | B2 |
7216651 | Argenta et al. | May 2007 | B2 |
7361184 | Joshi | Apr 2008 | B2 |
7367342 | Butler | May 2008 | B2 |
7494482 | Orgill et al. | Feb 2009 | B2 |
7524315 | Blott et al. | Apr 2009 | B2 |
7534927 | Lockwood | May 2009 | B2 |
7540848 | Hannigan et al. | Jun 2009 | B2 |
7611500 | Lina et al. | Nov 2009 | B1 |
7625362 | Boehringer et al. | Dec 2009 | B2 |
7699830 | Martin | Apr 2010 | B2 |
7708724 | Weston | May 2010 | B2 |
7753894 | Blott et al. | Jul 2010 | B2 |
7776028 | Miller et al. | Aug 2010 | B2 |
7790945 | Watson, Jr. | Sep 2010 | B1 |
7794450 | Blott et al. | Sep 2010 | B2 |
7811269 | Boynton et al. | Oct 2010 | B2 |
7846141 | Weston | Dec 2010 | B2 |
7883494 | Martin | Feb 2011 | B2 |
7901672 | Fraser et al. | Mar 2011 | B2 |
7909805 | Weston | Mar 2011 | B2 |
7927319 | Lawhorn | Apr 2011 | B2 |
7964766 | Blott et al. | Jun 2011 | B2 |
7998125 | Weston | Aug 2011 | B2 |
8062272 | Weston | Nov 2011 | B2 |
8062273 | Weston | Nov 2011 | B2 |
8080702 | Blott et al. | Dec 2011 | B2 |
8100887 | Weston et al. | Jan 2012 | B2 |
8105295 | Blott et al. | Jan 2012 | B2 |
8118794 | Weston et al. | Feb 2012 | B2 |
8128615 | Blott et al. | Mar 2012 | B2 |
8162909 | Blott et al. | Apr 2012 | B2 |
8235955 | Blott et al. | Aug 2012 | B2 |
8257327 | Blott et al. | Sep 2012 | B2 |
8308714 | Weston et al. | Nov 2012 | B2 |
8338402 | Fry et al. | Dec 2012 | B2 |
8348910 | Blott et al. | Jan 2013 | B2 |
8366692 | Weston | Feb 2013 | B2 |
8398614 | Blott et al. | Mar 2013 | B2 |
8414519 | Hudspeth et al. | Apr 2013 | B2 |
8529548 | Blott et al. | Sep 2013 | B2 |
8535296 | Blott et al. | Sep 2013 | B2 |
8545464 | Weston | Oct 2013 | B2 |
8569566 | Blott et al. | Oct 2013 | B2 |
20010034499 | Sessions et al. | Oct 2001 | A1 |
20020050535 | Igashira et al. | May 2002 | A1 |
20020161346 | Lockwood et al. | Oct 2002 | A1 |
20020183702 | Henley et al. | Dec 2002 | A1 |
20020198503 | Risk, Jr. et al. | Dec 2002 | A1 |
20020198504 | Risk et al. | Dec 2002 | A1 |
20030021775 | Freeman | Jan 2003 | A1 |
20030040687 | Boynton et al. | Feb 2003 | A1 |
20030050594 | Zamierowski | Mar 2003 | A1 |
20030097100 | Watson | May 2003 | A1 |
20030144619 | Augustine | Jul 2003 | A1 |
20030171675 | Rosenberg | Sep 2003 | A1 |
20040054338 | Bybordi et al. | Mar 2004 | A1 |
20040193218 | Butler | Sep 2004 | A1 |
20070014837 | Johnson et al. | Jan 2007 | A1 |
20070016152 | Karpowicz et al. | Jan 2007 | A1 |
20070038172 | Zamierowski | Feb 2007 | A1 |
20070055209 | Patel et al. | Mar 2007 | A1 |
20070073200 | Hannigan et al. | Mar 2007 | A1 |
20070118096 | Smith et al. | May 2007 | A1 |
20070239139 | Weston | Oct 2007 | A1 |
20080071216 | Locke et al. | Mar 2008 | A1 |
20080071234 | Kelch et al. | Mar 2008 | A1 |
20080082059 | Fink et al. | Apr 2008 | A1 |
20080200857 | Lawhorn | Aug 2008 | A1 |
20080200906 | Sanders et al. | Aug 2008 | A1 |
20080234641 | Locke et al. | Sep 2008 | A1 |
20090054855 | Blott et al. | Feb 2009 | A1 |
20090105671 | Daggar et al. | Apr 2009 | A1 |
20090163882 | Koch et al. | Jun 2009 | A1 |
20090221977 | Blott et al. | Sep 2009 | A1 |
20090306580 | Blott et al. | Dec 2009 | A1 |
20090312723 | Blott et al. | Dec 2009 | A1 |
20100036367 | Krohn | Feb 2010 | A1 |
20100312202 | Henley et al. | Dec 2010 | A1 |
20110004171 | Blott et al. | Jan 2011 | A1 |
20110009835 | Blott | Jan 2011 | A1 |
20110054423 | Blott et al. | Mar 2011 | A1 |
20110071483 | Gordon et al. | Mar 2011 | A1 |
20110172616 | Hartwell et al. | Jul 2011 | A1 |
20110213320 | Blott et al. | Sep 2011 | A1 |
20120004628 | Blott et al. | Jan 2012 | A1 |
20120041399 | Blott et al. | Feb 2012 | A1 |
20120130325 | Blott et al. | May 2012 | A1 |
20120157942 | Weston | Jun 2012 | A1 |
20120259297 | Blott et al. | Oct 2012 | A1 |
20130096519 | Blott | Apr 2013 | A1 |
Number | Date | Country |
---|---|---|
2 369 022 | Oct 2001 | CA |
3 935 818 | May 1991 | DE |
4 012 232 | Oct 1991 | DE |
198 44 355 | Apr 2000 | DE |
0 020 662 | Jul 1984 | EP |
0 777 504 | Oct 1998 | EP |
0 853 950 | Oct 2002 | EP |
1163907 | Oct 1958 | FR |
114754 | Apr 1918 | GB |
641061 | Aug 1950 | GB |
1224009 | Mar 1971 | GB |
1549756 | Aug 1979 | GB |
2195255 | Apr 1988 | GB |
2378392 | Feb 2003 | GB |
1251912 | Apr 1983 | SU |
WO 8401904 | May 1984 | WO |
WO 9011795 | Oct 1990 | WO |
WO 9100718 | Jan 1991 | WO |
WO 9219313 | Nov 1992 | WO |
WO 9220299 | Nov 1992 | WO |
WO 9727883 | Aug 1997 | WO |
WO 0007653 | Feb 2000 | WO |
WO 0050143 | Aug 2000 | WO |
WO 02083046 | Oct 2002 | WO |
WO 02092783 | Nov 2002 | WO |
WO 03053346 | Jul 2003 | WO |
WO 03101508 | Dec 2003 | WO |
WO 2004037334 | May 2004 | WO |
WO 200504670 | Jan 2005 | WO |
WO 2005105179 | Apr 2005 | WO |
WO 2005046760 | May 2005 | WO |
WO 2005105179 | Nov 2005 | WO |
WO 2006052745 | May 2006 | WO |
WO 2006114637 | Nov 2006 | WO |
WO 2007013064 | Feb 2007 | WO |
WO 2008010094 | Jan 2008 | WO |
WO 2008030872 | Mar 2008 | WO |
WO 2008036360 | Mar 2008 | WO |
WO 2008039314 | Apr 2008 | WO |
WO 2008048481 | Apr 2008 | WO |
WO 2009158131 | Dec 2009 | WO |
WO 2010083135 | Jul 2010 | WO |
Entry |
---|
The American Heritage® Science Dictionary Copyright © 2005. |
Aubrey, D.A., et al., Treatment of the Perineal Wound after Proctectomy by Intermittent Irrigation, Arch. Surg., Oct. 1984, 119, 1141-1144. |
Bagautdinov, N.A., “Variant of External Vacuum Aspiration in the Treatment of Purulent Diseases of Soft Tissues,” in current Problems in Modern Clinical Surgery: Interdepartmental Collection, edited by V. Ye. Volkov et al. (Chuvashia State University, Cheboksary, USSR 1986) pp. 94-96 (with English translation). |
Chariker, M.E., et al, “Effective Management of Incisional and Cutaneous Fistulae with Closed Suction Wound Drainage,” Contemporary Surgery. Jun. 1989, pp. 59-63, vol. 34 USA. |
Dilmaghani et al., “A Method for Closed Irrigation and Suction Therapy in Deep Wound Infections,” Journal of Bone and Joint Surgery, 1969, vol. 51-A, No. 2, pp. 323-342. |
Hartz, R.S., et al., Healing of the Perineal Wound, Arch. Surg., Apr. 1980, 115, 471-474. |
International Search Report mail Oct. 23, 2008 in International Application No. PCT/GB/2008/050510 in 5 pages. |
International Preliminary Report on Patentability and Written Opinion issued Jan. 5, 2010 in International Application No. PCT/GB/2008/050510 in 7 pages. |
NURSING75, Wound Suction: Better Drainage with Fewer Problems, Nursing, vol. 5, No. 10, Oct. 1975, pp. 52-55. |
Solovev, V. A., et al., “The Method of Treatment of Immature External Fistulas in the Upper Gastrointestinal Tract—Guidelines” USSR Ministry of Health, S. M. Kirov Gorky State Medical Institute, 1987 (with English translation). |
Svedman, P., “Irrigation Treatment in Split-Thickness Skin Grafting of Intractable Leg Ulcers,” Scand J. Plast. Reconst. Surg., 19:211-213, 1985. |
Svedman, P., “Irrigation Treatment of Leg Ulcers,” The Lancet, Sep. 1983, 532-34. |
Svedman, P., A Dressing Allowing Continuous Treatment of a Biosurface, IRCS Med. Science: Biomed. Tech.; Clinic. Med.; Surg. and Transplantation, 1979, 7, p. 221. |
Svedman, P., et al., “A Dressing System Providing Fluid Supply and Suction Drainage Used for Continuous or Intermittent irrigation,” Annals of Plastic Surgery, vol. 17, No. 2, Aug. 1986, pp. 125-133. |
Swift, et al, “Quorum Sensing in Aeromonas hydrophila and Aeromonas salmoncida: Identification of LuxRI Homologs AhyRI and AsaRI and Their Cognate N-Acylhomoserine Lactone Signal Molecules,” J. Bacteriol., 179(17):5271-5281 (1997). |
Teder and Svedman et al., “Continuous Wound Irrigation in the Pig,” Journal of Investigative Surgery, 1990, vol. 3, pp. 399-407. |
Tribble, David E. M.D., An Improved Sump Drain-Irrigation Device of Simple Construction, Archives of Surgery New York, pp. 511-13, 1972 vol. 105. |
Vijanto, J. and J. Raekallio, Local Hyperalimentation of Open Wounds, Br. J. surg., 1976, 63, 427-430. |
Westaby, S., et al., “A Wound Irrigation Device”, The Lancet, Sep. 2, 1978, pp. 503-504. |
Wooding-Scott, Margaret, et al., “No Wound is Too Big for Resourceful Nurses,” RN Dec. 1988, pp. 22-25 USA. |
Zivadinovic, Gorica, Veljko Dukic, Zivan Maksimovic, Dorde Radak and Predrag Pesko, Vacuum Therapy in the Treatment of Peripheral Blood Vessels, Timocki Medicinski Glasnik (Conference Papers of the 5th Timok Medical Days, Majdanepek, 1986), Year XI, Zajecar, 1986, No. 3-4, pp. 161-164 (with English translation). |
Japanese Office Action (Notice of Reasons for Rejection), re JP Application No. 2014-022317, dated Dec. 15, 2014. |
Number | Date | Country | |
---|---|---|---|
20140100538 A1 | Apr 2014 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12667232 | US | |
Child | 14019932 | US |